If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

is set to transform the chronic obstructive pulmonary disease (COPD) treatment. As the first interleukin (IL)-5-targeting monoclonal antibody in late-stage trials, Fasenra targets eosinophilic ...

If your healthcare provider has confirmed that your HER2+ and ER+ breast cancer has spread or cannot be surgically removed, it’s crucial to work closely with your healthcare team to develop a ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, antibiotics and other ... supplements and Covid-19 treatments on his television show ...

a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...